Prediction of gentamicin peak and trough concentrations from six extended-interval dosing protocols for neonates

American Journal of Health-System Pharmacy

Volumn 62, Issue 8, 2005, Pages 823-827

  Murphy, John E ^a,b  

^a Dept of Pharm Practice and Science ^*  (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

Aminoglycosides; Blood levels; Calculations; Dosage; Drugs, body distribution; Excretion; Gentamicin; Methodology; Pediatrics; Pharmacokinetics; Protocols; Rate constants; Toxicity

Indexed keywords

GENTAMICIN;

ARTICLE; BIRTH WEIGHT; DEMOGRAPHY; DISTRIBUTION VOLUME; DRUG BLOOD LEVEL; DRUG CLEARANCE; HUMAN; MATHEMATICAL ANALYSIS; NEWBORN; PATIENT CODING; PRIORITY JOURNAL;

EID: 17444379998     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/62.8.823     Document Type: Article

References (22)

1. De Cos MA, Gomez-Ullate J, Gomez F et al. Time course of trough serum gentamicin concentrations in preterm and term neonates. Clin Pharmacokinet. 1992; 23:391-401.
2. Glover ML, Shaffer CL, Rubino CM et al. A multicenter evaluation of gentamicin therapy in the neonatal intensive care unit. Pharmacotherapy. 2001; 21:7-10.
3. Robinson JD. Gentamicin monitoring in pediatric patients. Ann Pharmacother. 1997; 31:1539-40. Editorial.
4. Murphy JE, Carter JT, Evaluation of gentamicin therapy in newborns at a community hospital and development of simple dosing guidelines. Hosp Pharm. 1996; 31:1283-9.
5. Fisk KL. A review of gentamicin use in neonates. Neonatal Netw. 1993; 12:19-23.
6. Langlass TM, Mickle TR. Standard gentamicin dosage regimen in neonates. Am J Health-Syst Pharm. 1999; 56:440-3.
7. Krishnan L, George SA. Gentamicin therapy in preterms: a comparison of two dosage regimens. Indian Pediatr. 1997; 34:1075-80.
8. Murphy JE, Austin ML, Frye RF. Evaluation of gentamicin pharmacokinetics and dosing protocols in 195 neonates. Am J Health-Syst Pharm. 1998; 55:2280-8.
9. De Alba Romero C, Gomez Castillo E, Manzanares Secades C et al. Once daily gentamicin dosing in neonates. Pediatr Infect Dis J. 1998; 17:1169-71.
10. Miron D. Once daily dosing of gentamicin in infants and children. Pediatr Infect Dis J. 2001; 20:1169-73.
11. Uijtendaal EV, Rademaker CM, Schobben AF et al. Once-daily versus multiple-daily gentamicin in infants and children. Ther Drug Monit. 2001; 23:506-13.
12. Bass KD, Larkin SE, Paap C et al. Pharmacokinetics of once-daily gentamicin dosing in pediatric patients. J Pediatr Surg. 1998; 33:1104-7.
13. Young TE, Mangum OB. Neofax. 13th ed. Raleigh, NC: Acorn; 2000:31-2.
14. De Hoog M, Mouton JW, Schoemaker RC et al. Extended-interval dosing of tobramycin in neonates: implications for therapeutic drug monitoring. Clin Pharmacol Ther. 2002; 71:349-58.
15. Stolk LM, Degraeuwe PL, Nieman FH et al. Population pharmacokinetics and relationship between demographic and clinical variables and pharmacokinetics of gentamicin in neonates. Ther Drug Monit. 2002; 24:527-31.
16. Hansen A, Forbes P, Arnold A et al. Once-daily gentamicin dosing for the preterm and term newborn: proposal for a simple regimen that achieves target levels. J Perinatol. 2003; 23:635-9.
17. Rastogi A, Agarwal G, Pyati S et al. Comparison of two gentamicin schedules in very low birth weight infants. Pediatr Infect Dis J. 2002; 21:234-40.
18. DiCenzo R, Forrest A, Slish JC et al. A gentamicin pharmacokinetic population model and once-daily dosing algorithm for neonates. Pharmacotherapy. 2003; 23:585-91.
19. Patel R, Murphy JE. Use of pooled data to compare published and hospital-generated gentamicin dosing protocols for neonates. Paper presented at ASHP Midyear Clinical Meeting. Atlanta, GA; 2002 Dec 11.
20. Moore RD, Lietman PS, Smith CR. Clinical response to aminoglycoside therapy: importance of the ratio for peak concentration to minimal inhibitory concentration. J Infect Dis. 1987; 155:93-9.
21. Soldin OP, Soldin SJ. Review: therapeutic drug monitoring in pediatrics. Ther Drug Monit. 2002; 24:1-8.
22. Nicolau DP, Freeman CD, Belliveau PP et al. Experience with a once-daily aminoglycoside program administered to 2,184 adult patients. Antimicrob Agents Chemother. 1995; 39:650-5.